Across the commercialization continuum, Precision Value & Health teams are focused on transforming data for heath and leveraging evidence and insights to tailor communications for every stakeholder. From payers to health systems, scientists to healthcare providers, and consumers to advocates, our results are designed to shift the trajectory and accelerate your success.
Precision Value & Health’s teams include: PRECISIONadvisors (global pricing and market access strategy), PRECISIONeffect (branding and launch experts), PRECISIONheor (evidence generation and strategy), PRECISIONscientia (medical communications), PRECISIONvalue (managed markets marketing), PRECISIONxtract (data-driven solutions and engagement).
Jeremy spent 8 years at Prime Therapeutics, one of the top 5 largest PBMs. There, he held a variety of leadership roles in formulary, utilization management, and specialty pharmacy. Jeremy has experience in specialty pharmacy programs and networks, P&T Committee processes and review, prior authorization programs, fee schedule management, medical and pharmacy benefit integration, Medicare Part D, health outcomes research, contracting (rebate and specialty pharmacy), health plan and PBM strategy, and payer data analysis. Jeremy has also served as a Corporate Account Manager for Grifols where he engaged accounts including national payers, national PBMs, and significant regional payers to educate decision makers on Grifols’s portfolio and enhance access for providers and patients.
Jeremy provides enterprise leadership across Precision’s Access Experience Team and leads integration with other enterprise teams including health economics outcomes research, provider marketing, access and analytics, and media outreach in the specialty space. He has been involved in projects including payer value proposition development, ICER counter strategy marketing, market research in emerging areas like gene therapy and biosimilars, value assessment, and competitive simulations in oncology and specialty markets. Jeremy received his Master of Business Administration from Bethel University in St. Paul, Minnesota, and his Doctor of Pharmacy degree from the University of Minnesota in Minneapolis.
Dr. Pham is responsible for developing and refining Anthem’s provider payment models that reduce the cost of care while rewarding improvements in quality and access. Additionally, she is focused on developing new products and networks built on a foundation of value-based care, and overseeing Anthem’s Enhanced Personal Health Care initiative, a program that focuses on patient-centered care and reimburses doctors for value-based, rather than volume-based, performance. Prior to joining Anthem in 2017, she was a founding official at the Center for Medicare & Medicaid Innovation (CMMI), where she served as chief innovation officer and was responsible for implementation of the alternative payment model provisions of the Medicare Access and CHIP Reauthorization Act and other multi-organizational initiatives for the Center. Mai’s earlier work at CMMI included responsibility as the director of the Seamless Care Models Groups, overseeing the design and testing of models on accountable care organizations and advanced primary care, including the Pioneer and Next Generation ACO Models and Comprehensive Primary Care Initiative. A general internist, Mai has published extensively on payment policy issues including care fragmentation and coordination, and also practiced for several years at safety net clinics in the Washington D.C. area. Mai received her undergraduate degree from Harvard University, her MD from Temple University, and her MPH degree from Johns Hopkins, where she was also a Robert Wood Johnson Clinical Scholar.
GLI convenes the NASH Council, Liver Cancers Council, International NASH Day, and the Advanced Advocacy Academy, equipping liver patients to be effective advocates. www.globalliver.org and on Twitter @globalliver
Brian Diaz is the senior director of strategy with Wolters Kluwer Clinical Surveillance, Compliance and Data Solutions and is responsible for directing and managing the Health Language suite of content and service offerings. He has over 15 years of experience in healthcare information technology, including providing leadership in the areas of product management, marketing, and software development, and has a Bachelor of Science in Computer Engineering from the University of Minnesota.
The University of Colorado Pharmaceutical Value (pValue) initiative, led by Jonathan Campbell, PhD, and with the support of R. Brett McQueen, PhD, and Melanie D. Whittington, PhD, aims to apply and test novel methods for value assessment that encourages stakeholder engagement and promotes value-based decision making. pValue will initially focus on developing and testing multicriteria decision analysis as a novel method to estimate the value of innovative healthcare therapies. Findings will be compared to traditional assessments of value. The intent of pValue’s work is to promote an evidence-based approach for decision making. pValue includes a world-renowned Steering Committee alongside collaborators from Syreon Research Institute and Real Endpoints.
Blair's areas of focus include the OCM, broader implementation efforts surrounding value-based care, social determinants of health, and analysis of the changing oncology delivery landscape. Her primary interest stems from exploring the intersection of public health and healthcare in the oncology community. Prior to joining ACCC, Blair worked in care access and revenue cycle divisions of Huron Consulting Group, working with hospitals across the country.
John Figueroa, MBA, is a member of Pepperdine Graiziadio Business School board. Figueroa joined Genoa, a QoL Healthcare Company in July 2014 as chief executive officer (CEO), completing the successful merger of Genoa Healthcare and QoL meds. Genoa is the nation’s market-leading behavioral health pharmacy and telepsychiatry company serving 500,000+ individuals with severe mental health illnesses.
Previously, Figueroa served dual roles of chair and CEO of Apria Healthcare Group Inc., as well as that of Coram LLC. He holds bachelor’s degrees in both English literature and political science from the University of California, Los Angeles, where he was a distinguished military graduate. He also holds an MBA degree from Graziadio.
Prior to axialHealthcare, Meridith was a biostatistician and protocol manager for multi-center clinical trials conducted through the American College of Radiology Imaging Network at Brown University. She served full-time as a faculty member in Vanderbilt University Medical Center (VUMC) Department of Biostatistics, where she primarily collaborated within the Vanderbilt Institute for Global Health on observational cohort research in HIV/AIDS. Meridith is currently an Adjunct Instructor in the Department of Biostatistics at VUMC. She holds a bachelor’s degrees in statistics and sociology and a master’s degree in statistics from Case Western Reserve University. Meridith is lead or co-author on nearly 100 peer-reviewed publications (https://scholar.google.com/citations?hl=en&user=Ix2xcSsAAAAJ).
Sarah Alwardt, PhD. is vice president of Data, Evidence and Insights at McKesson and leads the real-world evidence and commercial intelligence operational teams. She is an accomplished leader with 15+ years of domestic and international experience in delivering data-driven insights for pharmaceutical companies. Prior to joining McKesson, Dr. Alwardt spent 10 years at Humana where she revitalized the research business and drove strategic planning for Humana Pharmacy Solutions.
Danielle K Roberts is a Medicare insurance expert and co-founder at Boomer Benefits, where she and her team help thousands of baby boomers with their Medicare supplemental insurance every year. Via online webinars and video email courses, she has taught the basics of Medicare to new beneficiaries across 47 states. Danielle is also a member of the Forbes Finance Council where she writes about the costs of healthcare in retirement.